Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Igor Splawski
Age : 52
Country of residence : Unknown
Linked companies : CureVac AG

Biography of Igor Splawski 
Presently, Igor Splawski occupies the position of Chief Scientific Officer for CureVac NV and Chief Scientific Officer for CureVac AG (a subsidiary of CureVac NV). In his past career he occupied the position of Executive Director at Novartis Institutes of Biomedical Research, Associate for Howard Hughes Medical Institute, Inc., Associate at The Children's Hospital Corp. and Assistant Professor at Harvard Medical School. Dr. Splawski received a doctorate from the University of Utah and a graduate degree from the University of Sofia.


Current positions of Igor Splawski 
Igor Splawski : Personal Network 
Most Read News 
09/04BERNARD ARNAULT : There is no conflict with Arnault
RE
09/07GEORGE SOROS : Soros says BlackRock's China investments likely to lose money - WSJ
RE
09/14BRAD SMITH : Microsoft to buy back up to $60 billion in shares; names Brad Smith vice chair
RE
09/09FRANCESCO GAETANO CALTAGIRONE : Italy's Caltagirone ups Generali stake to just over 6%
RE
09/14CATHIE WOOD : ARK Invest's Wood expects market rotation back to growth stocks
RE
09/09ELON MUSK : Tesla's Musk asks staff to 'go super hardcore' to ensure decent Q3 delivery number
RE
09/13MARTIN SORRELL : Sorrell's S4 Capital raises annual profit outlook for a third time
RE
09/08ELON MUSK : Amazon.com goes for jugular in FCC spat with SpaceX's Musk
RE
09/08BILL GATES : Bill Gates' investment firm to take control of Four Seasons in $2.21 billion deal
RE
09/17STELIOS HAJI-IOANNOU : EasyJet shareholder Stelios Haji-Ioannou shuns rights issue -source
RE
More news


© 2021 People and Ownership :   
Igor Splawski : Connections 


Latest news about Igor Splawski 
08/30CUREVAC N : Preclinical Data Shows Sharp Reduction of Liver Fibrosis With mRNA Therapeutic; Shares Down Midday
MT
08/30PRESS RELEASE : CureVac Preclinical Data Demonstrates Significant Reduction of Liver Fibrosis with mRNA Therapeutic
DJ
08/16PRESS RELEASE : CureVac : Second-Generation mRNA COVID-19 Vaccine Candidate, CV2CoV, Demonstrates Improved Immune Response and Protection in Preclinical Study
DJ
05/13PRESS RELEASE : CureVac : Second-Generation COVID-19 Vaccine Candidate, CV2CoV, Demonstrates High Immunogenicity Against Virus Variants in Preclinical Study
DJ
03/23PRESS RELEASE : CureVac's COVID-19 Vaccine Candidate, CVnCoV, Demonstrates Protection Against SARS-CoV-2 B.1.351 Variant (South African Variant) in Preclinical Challenge Study
DJ
More news